Compare Cassava Sciences Inc (FLNA) vs Hormel Foods Corp (HRL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Hormel Foods Corp — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while Hormel Foods Corp trades at $25.78 (market cap $13.84B). The key difference: Hormel Foods Corp is far larger — about 260.4× Cassava Sciences Inc's market cap, and Hormel Foods Corp pays a 4.65% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | HRL | |
|---|---|---|
Market Cap | $53.14M | $13.84B |
Sector | Health | Consumer Staples |
52-Week High | $4.64 | $29.91 |
52-Week Low | $1.09 | $19.74 |
Enterprise Value | -$33.43M | $15.84B |
Dividend Yield | — | 4.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
Hormel Foods (HRL) trades at $24.80, up 1.39% on the day, with a bullish technical signal from moving averages and recent earnings beats. The stock shows a P/E of 29.59 and net margin of 3.82%, while analyst consensus is mixed with a $26.33 price target. Recent business moves include selling its Brazilian Ceratti operations to streamline international focus, as reported by PRNewsWire on June 29, 2026.
The outlook presents a stable dividend play with 60 consecutive years of increases, but risks include margin pressure and competitive headwinds. Upside is supported by valuation near multi-year lows and consistent cash flow, while downside stems from modest growth and profit margin compression observed in 2025 financials.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Hormel Foods Corp
Hormel Foods is a protein-focused branded food company. Its brands include its namesake Hormel, Spam, Jennie-O, Dinty Moore, Applegate, Wholly Guacamole, and Skippy. The vast majority of the company's revenue is U.S.-based: 64% U.S. retail, 28% U.S. food service, and 8% international. By product type, in fiscal 2021, 23% of revenue was shelf-stable foods, 18% was poultry (branded and commodity), 55% was other perishable food, and 3% was other, primarily nutritional products. The company holds the number-one market position in shelf-stable meat, shelf-stable ready meals, pepperoni, natural/organic deli meat, and guacamole and the number-two position in turkey, bacon, chilled ready meals, and peanut butter.
Read more on HRL →
